Roman Manetsch

Sponsor: NIH

Strepothricin gulosamine derivatization to enhance selectivity against gram-negative

The emergence of multidrug-resistant gram-negative bacteria has compromised our ability to treat infections. Studies in this proposal build on novel chemical synthesis to explore variants of a natural product called strepothricin to provide a new therapy to treat these very problematic pathogens.